Cargando…
Release of Dengue Virus Genome Induced by a Peptide Inhibitor
Dengue virus infects approximately 100 million people annually, but there is no available therapeutic treatment. The mimetic peptide, DN59, consists of residues corresponding to the membrane interacting, amphipathic stem region of the dengue virus envelope (E) glycoprotein. This peptide is inhibitor...
Autores principales: | Lok, Shee-Mei, Costin, Joshua M., Hrobowski, Yancey M., Hoffmann, Andrew R., Rowe, Dawne K., Kukkaro, Petra, Holdaway, Heather, Chipman, Paul, Fontaine, Krystal A., Holbrook, Michael R., Garry, Robert F., Kostyuchenko, Victor, Wimley, William C., Isern, Sharon, Rossmann, Michael G., Michael, Scott F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511436/ https://www.ncbi.nlm.nih.gov/pubmed/23226444 http://dx.doi.org/10.1371/journal.pone.0050995 |
Ejemplares similares
-
Peptide inhibitors of dengue virus and West Nile virus infectivity
por: Hrobowski, Yancey M, et al.
Publicado: (2005) -
Structural Optimization and De Novo Design of Dengue Virus Entry Inhibitory Peptides
por: Costin, Joshua M., et al.
Publicado: (2010) -
A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins
por: Fibriansah, Guntur, et al.
Publicado: (2015) -
Neutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patient
por: Schieffelin, John S, et al.
Publicado: (2010) -
Capturing a Flavivirus Pre-Fusion Intermediate
por: Kaufmann, Bärbel, et al.
Publicado: (2009)